Company Filing History:
Years Active: 2008-2013
Title: The Innovative Mind of Levon Arakelyan
Introduction: Levon Arakelyan, an inventive force in the pharmaceutical realm, hails from Ashdod, Israel. With a total of three patents to his name, Arakelyan has made significant contributions to the field of drug development, showcasing his expertise and innovative spirit.
Latest Patents: Among his latest patents, two stand out due to their groundbreaking methodologies. The first patent, titled "Techniques for Puposing a New Compound and for Re-purposing a Drug," proposes a method for repurposing pharmaceutical compounds. This method focuses on identifying compounds corresponding to drugs that have failed in clinical trials or are already approved. By creating a mathematical model that describes physiological processes related to specific diseases and the impact of a pharmaceutical compound, it allows for the adjustment of this model based on clinical trial data. Ultimately, it suggests a new treatment protocol for utilizing previously failed drugs or finding new applications for approved ones, alongside systems and computer program products that encompass these techniques.
The second patent, "Interactive Technique for Optimizing Drug Development from the Pre-Clinical Phases through Phase-IV," outlines a method to conduct interactive clinical trials for new drug testing. The process includes developing and adjusting a computer model for pharmacokinetics and pharmacodynamics during the pre-clinical phase, alongside in vitro and in vivo studies. Clinical trials are designed to run parallel to computer simulations to determine the optimal protocols for responding patient populations, eventually leading to comprehensive phase I, II, and IV studies.
Career Highlights: Levon Arakelyan currently works with Optimata Ltd., where he is at the forefront of innovation in drug development. His expertise and contributions significantly advance the methodologies utilized within the company, underscoring his pivotal role in the research community.
Collaborations: Throughout his career, Arakelyan has collaborated with esteemed colleagues, including Zvia Agur and Vera Selitser. These partnerships not only enhance his projects but also foster a collaborative environment for breakthrough innovations in the field.
Conclusion: Levon Arakelyan's innovative contributions to pharmacology, with his significant patents and collaborations, reflect his dedication to improving drug development processes. His work not only aids in salvaging failed drugs but also opens up new pathways for approved medications, positioning him as a notable figure in contemporary pharmaceutical research.